Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00468286
Status:
COMPLETED
Last Update Posted:
2011-03-23
First Post:
2007-04-13
Brief Title:
Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Organization Data
Organization:
Ferring Pharmaceuticals
Class:
INDUSTRY
Study ID:
FE200486 CS18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ferring Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Clinical Development Support
Old Organization:
Ferring Pharmaceuticals